Swiss pharmaceuticals group Roche will sell its vitamins division to Dutch chemicals group DSM, reported the Badische Zeitung today [Wednesday].
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The paper says Roche has decided to sell off the vitamins unit because it is less profitable that its other operating units. The vitamin division is worth around SFr3.5bn (US2.2bn$), accounting for approximately 10% of Roche’s overall turnover of SFr29bn, reported Dow Jones.
A Roche spokesman declined to comment.
